Eiropas Savienība - latviešu - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil hidrohlorīds - kolorektālie jaunveidojumi - antineoplastiski līdzekļi - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Latvija - latviešu - Zāļu valsts aģentūra

pfizer europe ma eeig, belgium - flukonazols - kapsula, cietā - 150 mg

Latvija - latviešu - Zāļu valsts aģentūra

pfizer s.a, belgium - flukonazols - kapsula, cietā - 150 mg

Latvija - latviešu - Zāļu valsts aģentūra

meda pharma, sia, latvia - deproteinizēts teļca asiņu hemodializāts - acu gels - 8,3 mg/g

Latvija - latviešu - Zāļu valsts aģentūra

pfizer limited, united kingdom - flukonazols - Šķīdums infūzijām - 2 mg/ml